Skip to main content
Top
Published in: European Radiology 12/2014

01-12-2014 | Oncology

Diffusion-weighted MRI of the Prostate: Advantages of Zoomed EPI with Parallel-transmit-accelerated 2D-selective Excitation Imaging

Authors: Kolja M. Thierfelder, Michael K. Scherr, Mike Notohamiprodjo, Jakob Weiß, Olaf Dietrich, Ullrich G. Mueller-Lisse, Josef Pfeuffer, Konstantin Nikolaou, Daniel Theisen

Published in: European Radiology | Issue 12/2014

Login to get access

Abstract

Objectives

The purpose of our study was to evaluate the use of 2D-selective, parallel-transmit excitation magnetic resonance imaging (MRI) for diffusion-weighted echo-planar imaging (pTX-EPI) of the prostate, and to compare it to conventional, single-shot EPI (c-EPI).

Methods

The MRI examinations of 35 patients were evaluated in this prospective study. PTX-EPI was performed with a TX-acceleration factor of 1.7 and a field of view (FOV) of 150 × 90 mm2, whereas c-EPI used a full FOV of 380 × 297 mm2. Two readers evaluated three different aspects of image quality on 5-point Likert scales. To quantify distortion artefacts, maximum diameters and prostate volume were determined for both techniques and compared to T2-weighted imaging.

Results

The zoomed pTX-EPI was superior to c-EPI with respect to overall image quality (3.39 ± 0.62 vs 2.45 ± 0.67) and anatomic differentiability (3.29 ± 0.65 vs 2.41 ± 0.65), each with p < 0.0001. Artefacts were significantly less severe in pTX-EPI (0.93 ± 0.73 vs 1.49 ± 1.08), p < 0.001. The quantitative analysis yielded a higher agreement of pTX-EPI with T2-weighted imaging than c-EPI with respect to coronal (ICCs: 0.95 vs 0.93) and sagittal (0.86 vs 0.73) diameters as well as prostate volume (0.94 vs 0.92). Apparent diffusion coefficient (ADC) values did not differ significantly between the two techniques (p > 0.05).

Conclusions

Zoomed pTX-EPI leads to substantial improvements in diffusion-weighted imaging (DWI) of the prostate with respect to different aspects of image quality and severity of artefacts.

Key Points

Recent technical developments in MRI allow the use of accelerated, spatially-selective excitation (parallel-transmit, pTX)
pTX can be used for zoomed echo-planar prostate imaging (pTX-EPI)
pTX-EPI improves different aspects of image quality in prostate MRI
Distortion artefacts are reduced by the use of pTX-EPI in prostate MRI
Further studies should aim at assessing the diagnostic accuracy of pTX-EPI
Literature
2.
go back to reference Cornelis F, Rigou G, Le Bras Y et al (2013) Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings. Radiology 269:159–166PubMedCrossRef Cornelis F, Rigou G, Le Bras Y et al (2013) Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings. Radiology 269:159–166PubMedCrossRef
3.
go back to reference Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef Delongchamps NB, Rouanne M, Flam T et al (2011) Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 107:1411–1418PubMedCrossRef
4.
go back to reference Franiel T, Hamm B, Hricak H (2011) Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 21:616–626PubMedCrossRef Franiel T, Hamm B, Hricak H (2011) Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer. Eur Radiol 21:616–626PubMedCrossRef
5.
go back to reference Giles SL, Morgan VA, Riches SF, Thomas K, Parker C, deSouza NM (2011) Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components. AJR Am J Roentgenol 196:586–591PubMedCrossRef Giles SL, Morgan VA, Riches SF, Thomas K, Parker C, deSouza NM (2011) Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components. AJR Am J Roentgenol 196:586–591PubMedCrossRef
6.
go back to reference Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef Haider MA, van der Kwast TH, Tanguay J et al (2007) Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol 189:323–328PubMedCrossRef
7.
go back to reference Hambrock T, Somford DM, Huisman HJ et al (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259:453–461PubMedCrossRef Hambrock T, Somford DM, Huisman HJ et al (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259:453–461PubMedCrossRef
8.
go back to reference Hoeks CM, Somford DM, van Oort IM et al (2013) Value of 3-T Multiparametric Magnetic Resonance Imaging and Magnetic Resonance-Guided Biopsy for Early Risk Restratification in Active Surveillance of Low-Risk Prostate Cancer: A Prospective Multicenter Cohort Study. Investig Radiol. doi:10.1097/RLI.0000000000000008 Hoeks CM, Somford DM, van Oort IM et al (2013) Value of 3-T Multiparametric Magnetic Resonance Imaging and Magnetic Resonance-Guided Biopsy for Early Risk Restratification in Active Surveillance of Low-Risk Prostate Cancer: A Prospective Multicenter Cohort Study. Investig Radiol. doi:10.​1097/​RLI.​0000000000000008​
9.
go back to reference Kim CK, Park BK, Park W, Kim SS (2010) Prostate MR imaging at 3 T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 35:246–252PubMedCrossRef Kim CK, Park BK, Park W, Kim SS (2010) Prostate MR imaging at 3 T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging 35:246–252PubMedCrossRef
10.
go back to reference Kim CK, Park BK, Kim B (2010) Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 194:1461–1469PubMedCrossRef Kim CK, Park BK, Kim B (2010) Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 194:1461–1469PubMedCrossRef
11.
go back to reference Kim CK, Park BK, Lee HM (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3 T diffusion-weighted MRI. J Magn Reson Imaging : JMRI 29:391–397PubMedCrossRef Kim CK, Park BK, Lee HM (2009) Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3 T diffusion-weighted MRI. J Magn Reson Imaging : JMRI 29:391–397PubMedCrossRef
12.
go back to reference Murtz P, Kaschner M, Traber F et al (2012) Diffusion-weighted whole-body MRI with background body signal suppression: technical improvements at 3.0 T. J Magn Reson Imaging : JMRI 35:456–461PubMedCrossRef Murtz P, Kaschner M, Traber F et al (2012) Diffusion-weighted whole-body MRI with background body signal suppression: technical improvements at 3.0 T. J Magn Reson Imaging : JMRI 35:456–461PubMedCrossRef
13.
go back to reference Murtz P, Kaschner M, Traber F et al (2012) Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T. Eur J Radiol 81:3614–3623PubMedCrossRef Murtz P, Kaschner M, Traber F et al (2012) Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T. Eur J Radiol 81:3614–3623PubMedCrossRef
14.
go back to reference Reischauer C, Wilm BJ, Froehlich JM et al (2011) High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. Eur J Radiol 80:e34–e41PubMedCrossRef Reischauer C, Wilm BJ, Froehlich JM et al (2011) High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. Eur J Radiol 80:e34–e41PubMedCrossRef
15.
go back to reference Ren J, Huan Y, Wang H et al (2009) Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 19:2481–2486PubMedCrossRef Ren J, Huan Y, Wang H et al (2009) Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 19:2481–2486PubMedCrossRef
16.
go back to reference Rieseberg S, Frahm J, Finsterbusch J (2002) Two-dimensional spatially-selective RF excitation pulses in echo-planar imaging. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 47:1186–1193CrossRef Rieseberg S, Frahm J, Finsterbusch J (2002) Two-dimensional spatially-selective RF excitation pulses in echo-planar imaging. Magn Reson Med: Off J Soc Magn Reson Med / Soc Magn Reson Med 47:1186–1193CrossRef
17.
go back to reference Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:482–492PubMedCrossRef Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:482–492PubMedCrossRef
18.
go back to reference Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Investig Radiol 47:624–633CrossRef Selnaes KM, Heerschap A, Jensen LR et al (2012) Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Investig Radiol 47:624–633CrossRef
19.
go back to reference Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Investig Radiol 48:152–157CrossRef Somford DM, Hoeks CM, Hulsbergen-van de Kaa CA et al (2013) Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer. Investig Radiol 48:152–157CrossRef
20.
go back to reference Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Mag Reson imaging : JMRI 25:146–152CrossRef Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Mag Reson imaging : JMRI 25:146–152CrossRef
21.
go back to reference Thierfelder KM, Sommer WH, Baumann AB et al (2013) Whole-brain CT perfusion: reliability and reproducibility of volumetric perfusion deficit assessment in patients with acute ischemic stroke. Neuroradiology 55:827–835PubMedCrossRef Thierfelder KM, Sommer WH, Baumann AB et al (2013) Whole-brain CT perfusion: reliability and reproducibility of volumetric perfusion deficit assessment in patients with acute ischemic stroke. Neuroradiology 55:827–835PubMedCrossRef
22.
go back to reference Turkbey B, Merino MJ, Gallardo EC et al (2013) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology. J Mag Reson Imaging : JMRI. doi:10.1002/jmri.24317 Turkbey B, Merino MJ, Gallardo EC et al (2013) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: Correlation with whole-mount histopathology. J Mag Reson Imaging : JMRI. doi:10.​1002/​jmri.​24317
23.
go back to reference Ueno Y, Takahashi S, Kitajima K et al (2013) Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis. Eur Radiol 23:3509–3516PubMedCrossRef Ueno Y, Takahashi S, Kitajima K et al (2013) Computed diffusion-weighted imaging using 3-T magnetic resonance imaging for prostate cancer diagnosis. Eur Radiol 23:3509–3516PubMedCrossRef
24.
go back to reference Willinek WA, Gieseke J, Kukuk GM et al (2010) Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 256:966–975PubMedCrossRef Willinek WA, Gieseke J, Kukuk GM et al (2010) Dual-source parallel radiofrequency excitation body MR imaging compared with standard MR imaging at 3.0 T: initial clinical experience. Radiology 256:966–975PubMedCrossRef
25.
go back to reference Yoshizako T, Wada A, Hayashi T et al (2008) Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 49:1207–1213PubMedCrossRef Yoshizako T, Wada A, Hayashi T et al (2008) Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 49:1207–1213PubMedCrossRef
Metadata
Title
Diffusion-weighted MRI of the Prostate: Advantages of Zoomed EPI with Parallel-transmit-accelerated 2D-selective Excitation Imaging
Authors
Kolja M. Thierfelder
Michael K. Scherr
Mike Notohamiprodjo
Jakob Weiß
Olaf Dietrich
Ullrich G. Mueller-Lisse
Josef Pfeuffer
Konstantin Nikolaou
Daniel Theisen
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 12/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3347-y

Other articles of this Issue 12/2014

European Radiology 12/2014 Go to the issue